Remove 2002 Remove Diabetes Remove Packaging
article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

R&D Expenditure: $883M Founded Year: 2002 Total Employees: ~2000 Headquarters: Massachusetts, United States Market Cap: $25.4B Currently, the company is developing VIR-2218 under its HBV therapy programs in multiple collaborations with Anlylam, Brii Biosciences, and Gilead. R&D Expenditure: $3.5B R&D Expenditure: $14.6B

article thumbnail

Hashimoto’s and Graves’ Remission after Helicobacter Pylori Eradication

The Thyroid Pharmacist

This big news was newly emerging research in 2002 when I started pharmacy school, 20 years after their initial discovery. MegaGuard and PyloGuard provide doses on the package. J Diabetes Res. Finally, in 1994, the National Institutes of Health stated that most ulcers were in fact caused by H. pylori in people with ulcers. (17-21).